Clarity Financial’s Amgen AMGN Stock Holding History

Clarity Financial’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-976	Closed	-$243K	–	111
2021 Q1	$243K	Buy	+976	New	+$233K	0.05%	116

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Clarity Financial's AMGN Position: Q2 2021 in Review

Clarity Financial sold out of Amgen (AMGN) in Q2 2021, closing a stake of 976 shares — an estimated $243K sold.

Clarity Financial first reported a position in AMGN in Q1 2021 and held it in 1 quarter. The position peaked at $243K in Q1 2021. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

Clarity Financial reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
Clarity Financial sold 976 Amgen shares in Q2 2021, an estimated $243K.
Clarity Financial first reported a position in Amgen in Q1 2021 and held it in 1 quarter.
Clarity Financial's Amgen position peaked at $243K in Q1 2021.
2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Clarity Financial's 13F filing for Q2 2021, filed 13 Aug 2021.